Team:ETH Zurich/Achievements

From 2011.igem.org

(Difference between revisions)
(Modeling)
(Human Practices)
 
(5 intermediate revisions not shown)
Line 4: Line 4:
= SmoColi - Achievements =
= SmoColi - Achievements =
-
'''It has been a long four and a half months since we started working on our SmoColi project. During that time, we worked hard and learned a lot of new stuff. Below we summarize shortly what we did and what we have achieved so far. If you want to read more about a particular achievement, click on the respective link.'''
+
'''It has been a long four and a half months since we started working on our SmoColi project. During that time, we worked hard and learned a lot of new stuff. Below we summarize shortly what we did and what we have achieved so far. If you would like to read more about a particular achievement, click on the respective link.'''
{{:Team:ETH Zurich/Templates/SectionEnd}}
{{:Team:ETH Zurich/Templates/SectionEnd}}
Line 26: Line 26:
* We improved the pSB6A1 Plasmid to standard 5: [http://partsregistry.org/Part:BBa_K625005 '''pSB6A5''']
* We improved the pSB6A1 Plasmid to standard 5: [http://partsregistry.org/Part:BBa_K625005 '''pSB6A5''']
* We created the [http://partsregistry.org/Part:BBa_K625000 BioBrick '''LacI<sub>M1</sub>'''] which is a codon modified LacI for multiplasmid operations
* We created the [http://partsregistry.org/Part:BBa_K625000 BioBrick '''LacI<sub>M1</sub>'''] which is a codon modified LacI for multiplasmid operations
-
* We created [https://2011.igem.org/Team:ETH_Zurich/Biology/Validation#XylR_-_the_xylene_sensor two improved version of the '''P<sub>U</sub>''' BioBrick], characterized the P<sub>U</sub> promoter and fitted a dose response curve to the data
+
* We created [https://2011.igem.org/Team:ETH_Zurich/Biology/Validation#XylR_-_the_xylene_sensor two improved versions of the '''P<sub>U</sub>''' BioBrick], characterized the P<sub>U</sub> promoter and fitted a dose response curve to the data
* We characterized the [[Team:ETH_Zurich/Biology/Validation#AraC_-_the_arabinose_sensor|'''P<sub>BAD</sub>''']] dose response for homogenous expression of the P<sub>BAD</sub> in BW27783
* We characterized the [[Team:ETH_Zurich/Biology/Validation#AraC_-_the_arabinose_sensor|'''P<sub>BAD</sub>''']] dose response for homogenous expression of the P<sub>BAD</sub> in BW27783
* We successfully tested the '''channel''' in terms of '''cell viability and GFP synthesis'''
* We successfully tested the '''channel''' in terms of '''cell viability and GFP synthesis'''
-
* We could established a '''gradient of a small molecule''' (IPTG and arabinose) in a tube and also in the microfluidic channel
+
* We could establish a '''gradient of a small molecule''' (IPTG and arabinose) in a tube and also in the microfluidic channel
{{:Team:ETH Zurich/Templates/SectionEnd}}
{{:Team:ETH Zurich/Templates/SectionEnd}}
Line 37: Line 37:
=Microfluidics=
=Microfluidics=
* We [[Team:ETH_Zurich/Process/Validation|systematically came up with the current channel design]] through a [[Team:ETH_Zurich/Process/Microfluidics|process of developing and refining chain of ideas for different designs]].
* We [[Team:ETH_Zurich/Process/Validation|systematically came up with the current channel design]] through a [[Team:ETH_Zurich/Process/Microfluidics|process of developing and refining chain of ideas for different designs]].
-
* Modeling help to improved the channel design
+
* Modeling helped to improve the channel design
* We participated in the [[Team:ETH_Zurich/Process/Validation#Final Channel Construction|PDMS channel construction]].
* We participated in the [[Team:ETH_Zurich/Process/Validation#Final Channel Construction|PDMS channel construction]].
{{:Team:ETH Zurich/Templates/SectionEnd}}
{{:Team:ETH Zurich/Templates/SectionEnd}}
Line 48: Line 48:
* We also made a [[Team:ETH Zurich/Team/Human practices#Survey|'''survey''']] with critical questions related to Synthetic Biology and iGEM, asked people to fill it out and analyzed the results.
* We also made a [[Team:ETH Zurich/Team/Human practices#Survey|'''survey''']] with critical questions related to Synthetic Biology and iGEM, asked people to fill it out and analyzed the results.
* '''ETH GLOBE''' and '''NZZ''' (Neue Zeitung Zürich) will write about our participation at iGEM World Championship Jamboree
* '''ETH GLOBE''' and '''NZZ''' (Neue Zeitung Zürich) will write about our participation at iGEM World Championship Jamboree
-
* We helped the [[Team:Edinburgh/Collaboration#Thanks_to_ETH_Zurich|'''Edinburgh 2011 iGEM team''']] with '''debugging their [[Team:Edinburgh/Cellulases_(MATLAB_model)|MATLAB cellulase model]]'''.
 
{{:Team:ETH Zurich/Templates/SectionEnd}}
{{:Team:ETH Zurich/Templates/SectionEnd}}
{{:Team:ETH Zurich/Templates/SectionStart}}
{{:Team:ETH Zurich/Templates/SectionStart}}
 +
=Collaboration=
=Collaboration=
* We helped the [[Team:Edinburgh/Collaboration#Thanks_to_ETH_Zurich|'''Edinburgh 2011 iGEM team''']] with '''debugging their [[Team:Edinburgh/Cellulases_(MATLAB_model)|MATLAB cellulase model]]'''
* We helped the [[Team:Edinburgh/Collaboration#Thanks_to_ETH_Zurich|'''Edinburgh 2011 iGEM team''']] with '''debugging their [[Team:Edinburgh/Cellulases_(MATLAB_model)|MATLAB cellulase model]]'''

Latest revision as of 03:16, 29 October 2011

Can you feel the smoke tonight?
 

Contents

SmoColi - Achievements

It has been a long four and a half months since we started working on our SmoColi project. During that time, we worked hard and learned a lot of new stuff. Below we summarize shortly what we did and what we have achieved so far. If you would like to read more about a particular achievement, click on the respective link.


Modeling


Biology

  • After severe cloning difficulties (due to unexpected lethality of active CI and LacI), the final system was completely established.
  • We improved the pSB6A1 Plasmid to standard 5: [http://partsregistry.org/Part:BBa_K625005 pSB6A5]
  • We created the [http://partsregistry.org/Part:BBa_K625000 BioBrick LacIM1] which is a codon modified LacI for multiplasmid operations
  • We created two improved versions of the PU BioBrick, characterized the PU promoter and fitted a dose response curve to the data
  • We characterized the PBAD dose response for homogenous expression of the PBAD in BW27783
  • We successfully tested the channel in terms of cell viability and GFP synthesis
  • We could establish a gradient of a small molecule (IPTG and arabinose) in a tube and also in the microfluidic channel


Microfluidics


Human Practices

  • We presented Synthetic Biology and iGEM to our fellow students in the CBB get together afternoon.
  • We presented iGEM and our project to the general public on the BSSE Open House Day through a poster and a slide show.
  • We also made a survey with critical questions related to Synthetic Biology and iGEM, asked people to fill it out and analyzed the results.
  • ETH GLOBE and NZZ (Neue Zeitung Zürich) will write about our participation at iGEM World Championship Jamboree


Collaboration


Personal achievements

  • xx managed to move the Dropbox folder to another location, thus making it look empty for the others.
  • xx accidentally modified an other teams wiki for 1 min
  • xx and xy slept the whole boat trip in Amsterdam
  • xy found a mistake in the PowerPoint in the morning before the presentation ("And the channel turns read")
  • xy managed to sleep at two chairs in the lab
  • We had fun!


Back to iGEM Our Sponsors
ETHZ-BASF.png ETH Zurich Logo.png ETHZ-Lonza.png ETHZ-Merck Serono.png
ETHZ-Novartis.png ETHZ-Roche.png ETHZ-Syngenta.png DSM MasterLogo.png